TrialBMC cancer2012

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.

Josef Thaler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.